Drugmaker Backs Off Plan to Charge for Unproven ALS Therapy

(Bloomberg) -- BrainStorm Cell Therapeutics Inc. has decided not to make its unproven therapy for Lou Gehrig’s disease available to patients under a new U.S. law after struggling to find funding fo...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.